Literature DB >> 2324165

The application of age, period and cohort models to predict Swiss cancer mortality.

E Negri1, C La Vecchia, F Levi, A Randriamiharisoa, A Decarli, P Boyle.   

Abstract

In order to project trends in mortality from 11 major cancer sites in Switzerland to the end of the current century, a log-linear Poisson age/period/cohort model with arbitrary constraints on the parameters was used, fitted to the observed rates for the period 1950-84. One projection was based on the assumption of a total absence of change in the effect of period, the second was based on a linear extrapolation of the logarithms of the seven known periods, and the third was related to a series of a priori external epidemiological hypotheses, whenever available. For instance, coefficients below unity were used for lung and other tobacco-related neoplasms in men, since some decline in exposure to tobacco carcinogens was observed among Swiss men, and above unity for women since the prevalence of smoking has risen among successive generations of women. Although the method has limitations and uncertainties, several qualitative indications could be derived from this exercise. For instance, the various models suggest that the age-standardized mortality from oral cancer in men will probably increase up to the end of the century, even under the optimistic assumption of an appreciable decline in smoking, while cancer of the oesophagus is likely to level-off around current values, as other tobacco-related neoplasms, prostate cancer in men, and breast cancer in women will probably do. Some steady decline is predicted by various models fitted to the incidence of stomach and intestinal cancer in both sexes, and to ovarian cancer. Lung cancer will continue to rise in women but will stop rising in men, and it will possibly fall if the hypothesis of a decline in exposure to tobacco carcinogens proves correct. Although any prediction has, by definition, substantial difficulties and uncertainties, projections of cancer mortality in the near future are based on a substantial amount of information already available, and may offer valuable information for epidemiological inferences and health planning purposes.

Entities:  

Keywords:  Cancer; Causes Of Death; Demographic Factors; Developed Countries; Diseases; Estimation Technics; Europe; Mathematical Model; Models, Theoretical; Mortality; Neoplasms; Population; Population Characteristics; Population Dynamics; Population Projection; Research Methodology; Sex Factors; Switzerland; Western Europe

Mesh:

Year:  1990        PMID: 2324165     DOI: 10.1007/bf01612679

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Projections of lung cancer mortality in the United States: 1985-2025.

Authors:  C C Brown; L G Kessler
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

2.  Cancer mortality in Switzerland, 1951-1984: effects of age, birth cohort and period of death.

Authors:  F Levi; A Decarli; C La Vecchia; A Randriamiharisoa
Journal:  Schweiz Med Wochenschr Suppl       Date:  1988

3.  Models for temporal variation in cancer rates. I: Age-period and age-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

4.  Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

Authors: 
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

5.  Using age, period and cohort models to estimate future mortality rates.

Authors:  C Osmond
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

6.  Re: "Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979".

Authors:  P Boyle; C Robertson
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

7.  Age, period and cohort models applied to cancer mortality rates.

Authors:  C Osmond; M J Gardner
Journal:  Stat Med       Date:  1982 Jul-Sep       Impact factor: 2.373

8.  Effects of age, birth cohort and period of death on Swiss cancer mortality, 1951-1984.

Authors:  F Levi; C La Vecchia; A Decarli; A Randriamiharisoa
Journal:  Int J Cancer       Date:  1987-10-15       Impact factor: 7.396

9.  Non-contraceptive oestrogens and the risk of breast cancer in women.

Authors:  C La Vecchia; A Decarli; F Parazzini; A Gentile; C Liberati; S Franceschi
Journal:  Int J Cancer       Date:  1986-12-15       Impact factor: 7.396

10.  Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979.

Authors:  P Boyle; C Robertson
Journal:  Am J Epidemiol       Date:  1987-04       Impact factor: 4.897

View more
  6 in total

1.  Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening.

Authors:  B Cox; D C Skegg
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

2.  Cancer mortality in Switzerland, 1985-89.

Authors:  F Levi; C La Vecchia; A Randriamiharisoa
Journal:  Soz Praventivmed       Date:  1991

3.  How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates?

Authors:  Qingwei Luo; Julia Steinberg; Xue Qin Yu; Michael Caruana; Karen Canfell; Dianne L O’Connell
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

4.  Empirical evaluation of prediction intervals for cancer incidence.

Authors:  Bjørn Møller; Harald Weedon-Fekjaer; Tor Haldorsen
Journal:  BMC Med Res Methodol       Date:  2005-06-10       Impact factor: 4.615

5.  Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach.

Authors:  P P S Woo; T Q Thach; S T B Choy; S M McGhee; G M Leung
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

6.  Combining clinical and genomic covariates via Cov-TGDR.

Authors:  Shuangge Ma; Jian Huang
Journal:  Cancer Inform       Date:  2007-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.